EP300 (p300) mediated histone butyrylation is critical for adipogenesis

The master epigenetic enzyme EP300 (p300) besides having lysine acetyltransferase activity can also catalyse other acylation modifications (propionylation, butyrylation, crotonylation etc.), the physiological implications of which are yet to be established. Here we report that lysine butyrylation concomittantly increases during adipogenesis, along with increased butyryl CoA levels due to upregulated fatty acid metabolic pathways. To delineate the role of p300 catalysed butyrylation in adipogenesis, we have identified a semi-synthetic derivative (LTK-14A) of garcinol which specifically inhibited histone butyrylation without affecting acetylation. Treatment of 3T3L1 cells with LTK-14A significantly abolished adipogenesis by downregulation of genes related to adipogenesis presumably through the inhibition of H4K5 butyrylation. Administering the specific inhibitor to high fat diet fed C57BL6/J mice as well as genetically obese db/db mice led to an attenuation/decrease in their weight gain respectively. The reduced obesity could be at least partially attributed to the targeted inhibition of H4K5 butyrylation, as observed by immunofluorescence staining of the inhibitor treated mice liver sections and immunoblotting with histones extracted from epididymal fat pads. This report therefore not only for the first time causally links histone butyrylation with adipogenesis but also presents a novel small molecule modulator that could be developed for anti-obesity therapeutics.

On the Quest of Small Molecules that Can Mimic Psalmotoxin-1, a Powerful Peptidic Modulator of the Acid Sensing Channel ASIC1a

Acid-sensing ion channels (ASICs) are thought to play a key role in a number of pathologies, from neuronal injury to pain sensation, while no drug has yet been approved as their modulator. This work was devised to asses roughly, yet from first principles, the relative energies of binding in the most important acidic pocket of cASIC1a, thereby paving the way to find small molecules that can mimic Pctx1, the most powerful peptidic modulator of cASIC1a. To this end, MD simulations for the overall conformation, and QM-MM simulations specifically for the location of hydrogen atoms, allowed disentangling the relative weight of the various non-bonded interactions between PcTx1 and cASIC1a. Main weight could be attributed to deeply buried salt bridges formed by the guanidinium end chains of residues Arg26 and Arg27 on PcTx1 and carboxylate end chain of distant residues Asp and Glu on cASIC1a. Rewardingly, in a preliminary attempt at exploiting these observations toward a small-molecule modulator, a Arg26-Arg27 stretch, excised from the PcTx1-cASIC1a complex and slightly simplified, on automated rigid docking on ligand-free receptor was observed to form most of the above salt bridges.

ASSESSING THE ROLE OF ARTIFICIAL INTELLIGENCE IN THE DESIGN OF DRUG DELIVERY SYSTEMS

Over ten years, increasing the interest has been fascinated towards the appeal of intelligent retrieval (IR) technology for data interpretation and illuminate the biological or transmitted information, speed up drug invention, and pinpointing of the selective small-molecule modulator control or rare particle and projection of their behavior. To make use of biomaterials, synthetic resin, fats, along IR is upcoming for the manufacture of drug deliverables. The request of the computerized workflows and databases for quick calculation of the vast amounts of data and artificial neural networks (ANNs) for growth of the narrative proposition and treatment schemes, forecast of disease development, and judgment of the pharmacological description of drug candidates may consequently improve treatment outcomes. Target fishing (TG) by quick projection or identification of the biological quarry might be of great help for linking quarry to the new substance.AI and TF methods in union with human knowledge may indeed transform the present-day diagnostic strategies, meanwhile verifying approaches are necessary to overcome the possible challenges and make certain higher perfection. In this review, the importance of AI and TF in the growth of drugs and transport systems and the possible challenging topics have been spotlighted. Keywords: Artificial intelligence; biomaterials, polymers, lipids, Drug Delivery.